Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pressure BioSciences Inc. PBIO

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Discusses Recent Company Activities in Interview on Uptick Newswire’s “Stock Day” Podcast

Global life sciences company Pressure BioSciences Inc.’s (OTCQB: PBIO) president and CEO Richard T. Schumacher was recently interviewed on Uptick Newswire’s “Stock Day” podcast. Among other highlights of the interview, Schumacher discussed the company’s sustained financial success, the noteworthy amount … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences, Inc. (PBIO) Announces $7.24M Debt-to-Equity Swap as it Prepares for 2018 Uplisting to National Stock Exchange

Equity swap further boosts Pressure BioSciences’ plans to uplist to a major stock exchange later this year Latest deal brings total debt-to-equity conversions to over $13.6M in past 30 days 2015/2016 debentures, line-of-credit and promissory note, plus various short-term debt, … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Conversion of Additional $7.24M of Debt into Equity

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced the conversion of an additional $7.24 million of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Boosts Drug Development Process through Acquisition of PreEMT™ Platform

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently acquired the PreEMT™ platform to develop a unique manufacturing method and improve the quality of a key protein-based drug being developed. A recent article discussing the company reads: “The acquisition of … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc.’s (PBIO) Recently Acquired PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs

Biologics offer novel ways of treating degenerative diseases like Alzheimer’s Biologics are one of the fastest-growing drug categories PreEMT™ technology improves quality, reduces cost of biologic manufacture When we think of drugs, an image of potions in round-bottom flasks conjured … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Increase in Revenue, Debt Conversion in Q1 2018

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. Among other highlights, the company reported first quarter revenue growth and debenture conversion. An article discussing the report further reads: … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Revenue Growth, Debt Conversion Boost Pressure BioSciences’ (PBIO) Outlook at Close of First Quarter

High-pressure lab equipment maker reports ninth consecutive quarter of revenue growth (Y/Y) About 92 percent of debenture debt converted to preferred stock, with aim of uplisting to national stock exchange Patented technologies continue to drive optimism for company’s products to … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Q1 Financial Results, Provides Business Update; Schedules Earnings Call

Global life sciences company Pressure BioSciences (OTCQB: PBIO) today announced financial results for the first quarter ended March 31, 2018. Among other highlights, Pressure BioSciences reported total revenue of $610,774 for the first quarter of 2018 compared to $551,357 for … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Agreement Related to Recently Acquired PreEMT™ Platform

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) today announced that it has signed an agreement with an international biopharmaceutical company to assess the potential of PBIO’s recently acquired PreEMT™ platform to develop a unique manufacturing process and improve … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO to Host Webinar on May 2

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that Richard T. Schumacher, the company’s president and CEO, will be hosting a webinar update and live Q&A session for investors today at 3:00 pm EDT. Per the … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment